Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Pfizer (NY: PFE )

29.16 -0.18 (-0.61%)
Official Closing Price Updated: 7:00 PM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Pfizer’s Seasonal Strength And Starboard’s Activist Move
Starboard's involvement signals frustration over Pfizer’s recent setbacks, including costly acquisitions that haven’t delivered expected returns. 
Via Talk Markets
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names
The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's dominance while addressing scalability and pricing concerns. 
Via Benzinga
U.S. FDA Approves Pfizer’s HYMPAVZI™ (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors
From Pfizer Inc.
Via Business Wire
Stock Market Rallies As S&P 500, Dow Hit Highs; Tesla Robotaxi Isn't Hailed, Delta, JPMorgan In Focus: Weekly Review
A number of leading stocks flashed buy signals over the past week. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
(PFE) - Analyzing Pfizer's Short Interest
Via Benzinga
Why Pfizer Stock Popped on Monday
Can Starboard Value and former CEO Ian Read save Pfizer stock? 
Via The Motley Fool
An Activist Investor Just Bought $1 Billion Worth of Pfizer. Here's What It Means for the Stock
There may be changes coming to this company, if the activists get their way. 
Via The Motley Fool
Why Pfizer Stock Tumbled by Nearly 3% on Thursday
The company's latest institutional shareholder has made some troubling allegations against it. 
Via The Motley Fool
GSK, Pfizer Face Declining Respiratory Syncytial Virus Vaccine Sales Due To Narrow Age Recommendations
RSV vaccine sales from GSK and Pfizer have dropped significantly following revised CDC guidelines, narrowing the eligible age group and reducing demand by two-thirds compared to last year. 
Via Benzinga
Personalized Treatment And Immunotherapy Are Pharma's Newest Weapons Against Cancer
On Sunday, The Guardian issued an article that spoke of a UK study that could transform how cancer is treated. The large-scale clinical project assessed how personalized cancer therapies could... 
Via Benzinga
What's Going On With Pfizer Stock On Thursday?
Starboard Value engages with Pfizer's leadership amid growing concerns over the company's trajectory. Meanwhile, Pfizer reports a significant survival benefit in prostate cancer patients from its... 
Via Benzinga
Pfizer Skids After Former Execs Flip On Activist Investor, Siding With CEO Albert Bourla
Ian Read and Frank D'Amelio say they are now "fully supportive" of CEO Albert Bourla. 
Via Investor's Business Daily
Pfizer’s TALZENNA® in Combination with XTANDI® Prolongs Overall Survival in Phase 3 TALAPRO-2 Trial
From Pfizer Inc.
Via Business Wire
2 No-Brainer Healthcare Stocks to Buy With $200 Right Now
Both of these stocks should have plenty of room to run. 
Via The Motley Fool
Former Pfizer Executives Ian Read And Frank D'Amelio Support Albert Bourla's Leadership Amid Starboard Activism: 'Will Deliver Shareholder Value'
Former Pfizer Inc CEO Ian Read and ex-CFO Frank D'Amelio have decided to distance themselves from the activist campaign led by Starboard Value at the pharmaceutical giant. 
Via Benzinga
Why Pfizer Stock Popped Today
The sharp, sudden entry of an activist investor is raising hopes that change might come to the company. 
Via The Motley Fool
Pfizer Declares Fourth-Quarter 2024 Dividend
From Pfizer Inc.
Via Business Wire
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
The Biden administration's proposed Medicare $2 Drug List Model aims to provide low-cost generic drugs for seniors and people with disabilities, with copayments capped at $2 per month for essential... 
Via Benzinga
S&P 500 Hits New All-Time High Ahead Of Fed Minutes As Lower Oil Prices Offer Relief: What's Driving Markets Wednesday?
The S&P 500 climbed 0.5% during morning trading in New York, reaching a new all-time high by surpassing the 5,770 level, previously touched in late September. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Billionaire Ken Griffin Just Bought 7.9 Million Shares of This Beaten-Down Pharmaceutical Stock as It Eyes the Weight Loss Market
Ken Griffin's Citadel continues to add to its position in Pfizer. 
Via The Motley Fool
These 3 Stocks Just Spiked—Buy the Rally or Sell the News?
Investors received news about three stocks that moved each stock higher, but now investors have to decide whether to buy the rally or take some profits 
Via MarketBeat
As a Billionaire Activist Takes a Stake, Is Now the Time to Buy Pfizer Stock?
Starboard will look to turn around the struggling pharma company. 
Via The Motley Fool
Pfizer CEO Albert Bourla Set To Meet Activist Investor Starboard Value As Pressure Mounts To Revitalize Struggling Stock: Report
Pfizer Inc. CEO Albert Bourla is set to meet with activist investor Starboard Value amid growing pressure to revitalize the pharmaceutical giant's struggling share price and refine its strategic focus.... 
Via Benzinga
Pfizer to Showcase Scientific Advancements in Respiratory and Other Infectious Diseases at IDWeek 2024
From Pfizer Inc.
Via Business Wire
Fifth Avenue Animate Launches New Website to Highlight Expertise in SaaS and Finance Video Marketing
Mississauga, Ontario () October 8, 2024 -- Agency continues to deliver high-impact animated content, helping businesses explain complex concepts and drive customer engagement. 
Via Prodigy
Biotech Stocks Poised For Another Big Move In Q4
The healthcare sector can be a safe haven if volatility increases. 
Via Talk Markets
Pfizer Wins London Court Battle, GSK's Respiratory Syncytial Virus Vaccine Patents Invalidated
Pfizer sees stock gains following a $1 billion investment by Starboard Value and a favorable UK court ruling invalidating two GSK RSV vaccine patents. Pfizer and GSK continue their legal battles as... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Starboard Value Reportedly Acquires $1B Stake In Pfizer As Stock Lags S&P 500 By 46%
Activist investor Starboard Value has reportedly taken a $1 billion stake in pharmaceutical giant Pfizer. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Pfizer Stock Is Moving Higher Monday: What's Driving The Action?
Pfizer Inc (NYSE:PFE) shares are on the move Monday after activist Starboard Value acquired a $1 billion stake in the pharmaceutical giant. 
Via Benzinga
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.